Neumora Therapeutics Inc.... (NMRA)
1.04
-0.06 (-5.45%)
At close: Mar 28, 2025, 2:10 PM
Neumora Therapeutics Common Stock Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 142.15M | 374.04M | 240.94M | 409.25M | 191.98M | n/a |
| Short-Term Investments | 165.43M | 79.94M | 130.94M | n/a | n/a | n/a |
| Long-Term Investments | n/a | 9.85M | 23.51M | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | 1.21M | 4.13M | 9.65M | 183K | n/a |
| Receivables | n/a | 939K | 919K | 200K | 148K | n/a |
| Inventory | n/a | n/a | 50K | 125K | n/a | n/a |
| Other Current Assets | 6.48M | 23.36M | 15.15M | 6.16M | 1.72M | n/a |
| Total Current Assets | 314.06M | 478.28M | 387.95M | 415.6M | 193.84M | n/a |
| Property-Plant & Equipment | 2.92M | 6.86M | 10.64M | 4.04M | 3.92M | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 2.92M | 17.92M | 38.28M | 13.69M | 4.11M | n/a |
| Total Assets | 316.97M | 496.19M | 426.23M | 429.3M | 197.95M | n/a |
| Account Payables | 3.31M | 337K | 7.15M | 1.64M | 2.4M | n/a |
| Deferred Revenue | n/a | n/a | 11.54M | 19.1M | 5.6M | n/a |
| Short-Term Debt | 1.85M | 3.38M | 3.37M | 1.06M | 764K | n/a |
| Other Current Liabilities | 24.73M | 21.4M | 13.18M | 20.58M | 6.21M | 21K |
| Total Current Liabilities | 29.89M | 25.11M | 23.7M | 23.28M | 9.37M | 21K |
| Long-Term Debt | n/a | 1.85M | 5.07M | 996K | 1.28M | n/a |
| Other Long-Term Liabilities | 22K | 155K | 844.32M | 730.24M | 281.68M | n/a |
| Total Long-Term Liabilities | 22K | 2.01M | 849.39M | 731.24M | 282.96M | n/a |
| Total Liabilities | 29.91M | 27.12M | 873.08M | 754.52M | 292.33M | 21K |
| Total Debt | 1.85M | 5.23M | 8.44M | 2.05M | 2.04M | n/a |
| Common Stock | 16K | 16K | 16K | 14K | 13K | n/a |
| Retained Earnings | -947.22M | -703.43M | -467.51M | -336.61M | -99.29M | -21K |
| Comprehensive Income | 62K | -76K | -774K | -729.86M | n/a | n/a |
| Shareholders Equity | 287.06M | 469.08M | -446.85M | -325.22M | -94.38M | -21K |
| Total Investments | 165.43M | 89.79M | 154.45M | n/a | n/a | n/a |